Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. — CFSMEATLAS
E2 ModerateModerate confidencePEM not requiredLongitudinalPeer-reviewedMachine draft
Standard · 3 min
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.
Hanlon, Peter, Nicholl, Barbara I, Jani, Bhautesh Dinesh et al. · The Lancet. Public health · 2018 · DOI
Quick Summary
This large study looked at nearly 500,000 people aged 37-73 to understand 'frailty'—a condition where people become weak and tired more easily. The researchers found that frailty is associated with having multiple health conditions and an increased risk of death over 7 years. Importantly, they discovered that chronic fatigue syndrome was one of the top five conditions linked to frailty, suggesting that frailty affects not just elderly people but also middle-aged adults with long-term illnesses.
Why It Matters
This study provides epidemiological evidence that ME/CFS is among the most strongly associated conditions with frailty in middle-aged adults, validating patient experience of profound disability. For ME/CFS researchers and clinicians, the finding that frailty—independent of condition count—predicts mortality underscores the need to assess functional decline and physical weakness as distinct clinical outcomes in ME/CFS cohorts.
Observed Findings
Chronic fatigue syndrome showed the second-highest odds ratio for frailty (12.9; 95% CI 11.1-15.0) among all long-term conditions examined.
Frailty was present in 3% of the cohort (16,538/493,737) and pre-frailty in 38% (185,360), with prevalence increasing by age group.
Frailty was significantly associated with mortality across all age strata in men and most age strata in women, even after adjustment for multimorbidity count, socioeconomics, and lifestyle factors.
Among participants with four or more long-term conditions, 18% met frailty criteria (OR 27.1 vs. those with fewer conditions).
The five conditions most strongly associated with frailty were multiple sclerosis (OR 15.3), CFS (12.9), COPD (5.6), connective tissue disease (5.4), and diabetes (5.0).
Inferred Conclusions
Frailty assessment should extend to middle-aged populations with multimorbidity, not just the elderly, particularly those with conditions like ME/CFS that confer high frailty risk.
Clinical care and research must shift from single-disease management to assessment of functional decline and frailty phenotype in complex patients.
Frailty is an independent mortality risk marker that adds information beyond condition count alone, suggesting it captures important pathophysiological or functional dimensions.
Remaining Questions
What are the specific mechanisms by which ME/CFS produces frailty phenotype criteria (exhaustion, reduced activity, slow walking) versus other chronic diseases?
What This Study Does Not Prove
This study does not establish that frailty *causes* mortality or that the specific mechanisms linking ME/CFS to frailty are understood. The association between ME/CFS and frailty is correlational and may reflect shared underlying pathophysiology, disease severity, or unmeasured confounders. The study also does not distinguish whether frailty in ME/CFS patients reflects post-exertional malaise, deconditioning, or other disease-specific processes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Does frailty in ME/CFS patients reflect post-exertional malaise, deconditioning, or autonomous nervous system dysfunction, and are these amenable to intervention?
Could longitudinal tracking of frailty criteria in ME/CFS cohorts identify subgroups at highest mortality risk and guide personalized management strategies?
How do activity-limiting aspects of frailty assessment (grip strength, walking pace) perform in ME/CFS populations where symptom fluctuation and post-exertional worsening complicate testing?